Eine maßgeschneiderte Bewerbung für diese Stelle — ein maßgeschneiderter Lebenslauf und ein Anschreiben, die genau zur Stellenanzeige passen.
ETH Zurich in Basel invites postdoctoral researchers to join the Biosystems Science and Engineering group to advance bioelectronic medicine. The project blends synthetic biology, nanotechnology, and electrical engineering to create programmable cells that respond to electrical and biochemical cues for real-time therapeutic control.
The successful candidate will work on catalyst engineering, computational simulation, device fabrication, and software development for closed-loop cellular regulation
100%, Basel, fixed-term
print Drucken
A World-Class Research Environment at the Nexus of Biology, Engineering, and Physical Sciences
The Biotechnology and Bioengineering group led by Prof. Dr. Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel invites exceptional candidates to apply for a Postdoc position in pioneering projects at the intersection of synthetic biology, nanotechnology, and bioelectronics.
The D-BSSE is ETH Zurich's first truly interdisciplinary research department uniting theoretical and experimental biology with advanced bioengineering and fostering close collaborations with leaders in materials science, physics, and chemistry to drive transformative advances in systems biology, biotechnology, and synthetic biology. Situated in Basel, Switzerland, at the heart of the BioValley, a tri-national region that hosts 40% of the global life sciences industry and numerous major pharmaceutical companies, the D-BSSE offers a unique environment for high-impact translational research with unparalleled access to academic and industrial expertise.
Project background
Advancing the Frontiers of Bioelectronics and Synthetic Biology
Our group integrates state-of-the-art synthetic biology with advanced nanotechnology, and electrogenetic interfaces to engineer human cells for next generation bioelectronic medicine, designing programmable cells that respond to electrical, electromagnetic, acoustic and biochemical cues to achieve wireless, real-time control of therapeutic protein expression and metabolic regulation. Leveraging innovative platforms such as direct-current-actuated regulation, electromagnetic programming of wireless expression, and closed-loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as well as metabolic, neurodegenerative, autoimmune, and infectious diseases.
Job Description